Five-year outcomes following hypofractionated stereotactic radiotherapy delivered in five fractions for acoustic neuromas: the mean cochlear dose may impact hearing preservation.

Zhiping ChenKeiichi TakehanaTakashi MizowakiMegumi UtoKengo OguraKatsuyuki SakanakaYoshiki ArakawaYohei MineharuYuki MiyabeNobutaka MukumotoSusumu MiyamotoMasahiro Hiraoka

Published in: International journal of clinical oncology (2018)

Hypo-FSRT delivered in five fractions for unilateral ANs may achieve excellent tumor control with no severe facial or trigeminal complications. The mean BED3 in the cochlea may impact the hearing preservation rate. Therefore, the cochlear dose should be as low as possible.

Keyphrases

hearing loss
radiation therapy
early stage
brain metastases
small cell lung cancer
early onset
locally advanced
squamous cell carcinoma
radiation induced
rectal cancer
soft tissue